# LRRC40

## Overview
The LRRC40 gene encodes the leucine-rich repeat containing 40 protein, which is characterized by the presence of 20 leucine-rich repeat (LRR) domains. These domains are known for facilitating protein-protein interactions, suggesting that LRRC40 may play a significant role in cellular communication and signaling pathways. Although the precise function of the LRRC40 protein is not fully understood, it is implicated in neuronal pathways and neurodevelopmental processes, potentially through its interaction with other proteins such as PlxnA2. This interaction is particularly relevant in the context of neurodevelopmental disorders, where alterations in LRRC40 have been associated with conditions such as autism spectrum disorder and epilepsy. Additionally, LRRC40 has been identified in prognostic models for certain cancers, indicating its potential involvement in oncological processes. Despite these associations, further research is needed to fully elucidate the molecular mechanisms and clinical significance of LRRC40 (Huang2022Identification; Pijuan2021PLXNA2; Cui2022Comprehensive).

## Structure
The LRRC40 gene encodes a protein characterized by the presence of 20 leucine-rich repeat (LRR) domains, which are known for facilitating protein-protein interactions (Pijuan2021PLXNA2). These LRR domains contribute to the protein's secondary structure, typically forming alpha-helices and beta-sheets, providing a structural framework for molecular interactions (Pijuan2021PLXNA2). The protein's function is not fully understood, but it is suggested to be involved in neuronal pathways due to its structural features and potential interactions (Pijuan2021PLXNA2).

A specific missense variant, p.Leu487Phe, located within the LRR domain, has been identified and is conserved across phylogenetically distant organisms. This variant is predicted to be damaging and slightly affects the secondary structure of the protein, indicating its potential impact on protein stability and function (Pijuan2021PLXNA2). The LRRC40 protein is primarily localized in the nucleoli and slightly in the cytoplasm of fibroblasts, with low protein levels observed in certain conditions, suggesting low stability of the variant protein (Pijuan2021PLXNA2). The protein may undergo post-translational modifications such as phosphorylation, which could influence its function and interactions, although specific modifications have not been detailed in the context provided.

## Function
The LRRC40 gene encodes a protein characterized by 20 leucine-rich repeats (LRR) in its structure, which are typically involved in protein-protein interactions. While the specific function of LRRC40 in healthy human cells is not fully understood, it is suggested to participate in neuronal pathways due to its structural features and interactions (Pijuan2021PLXNA2). The protein is a member of the LRR family, which provides a framework for molecular interactions, potentially acting as a ligand interaction domain (Pijuan2021PLXNA2).

LRRC40 has been observed to interact with PlxnA2, a gene implicated in neurodevelopmental disorders, suggesting a role in neurodevelopmental processes (Pijuan2021PLXNA2). This interaction is notably reduced in certain pathological conditions, indicating its potential importance in maintaining normal cellular functions (Pijuan2021PLXNA2). The protein's stability appears to be crucial, as variants affecting its structure can lead to decreased protein levels despite normal mRNA expression, highlighting its role in cellular homeostasis (Pijuan2021PLXNA2).

Overall, while the precise molecular activities of LRRC40 remain to be fully elucidated, its involvement in protein interactions and potential role in neuronal pathways suggest it plays a significant part in cellular and organismal functions.

## Clinical Significance
Mutations and alterations in the LRRC40 gene have been implicated in several neurodevelopmental and oncological conditions. In the context of autism spectrum disorder (ASD), a study identified a homozygous missense variant c.1461G>T (p.Leu487Phe) in the LRRC40 gene in a patient with ASD, epilepsy, and attention deficit hyperactivity disorder. This variant was predicted to be damaging and was associated with significantly lower levels of LRRC40 protein in the patient's fibroblasts, suggesting low protein stability. The study also found a decreased interaction between LRRC40 and PLXNA2, indicating a potential role in neural pathways related to ASD (Pijuan2021PLXNA2).

In oncology, LRRC40 has been identified as part of a 12-gene signature associated with the prognosis of Wilms tumor. Although LRRC40 was significantly associated with patient prognosis in univariate analysis, it was not highlighted as an independent predictor in multifactor analysis. This suggests that while LRRC40 may play a role in the prognosis of Wilms tumor, its independent clinical significance remains unclear (Huang2022Identification). Additionally, LRRC40 was included in a prognostic model for acute myeloid leukemia, indicating its potential relevance in cancer prognosis (Cui2022Comprehensive).

## Interactions
LRRC40, a protein encoded by the LRRC40 gene, is involved in protein-protein interactions, particularly through its leucine-rich repeat (LRR) domain, which provides a structural framework for such interactions. The study by Pijuan et al. identified a homozygous missense variant, p.Leu487Phe, in the LRR domain of LRRC40, suggesting its potential role in ligand interactions (Pijuan2021PLXNA2). This variant is conserved across phylogenetically distant organisms, indicating its importance in maintaining protein function.

LRRC40 has been shown to interact constitutively with PlxnA2 in fibroblasts. This interaction is significantly decreased in fibroblasts from a patient with autism spectrum disorder (ASD), epilepsy, and attention deficit hyperactivity disorder, suggesting a potential role in a common neural pathway related to axon guidance (Pijuan2021PLXNA2). The study also indicates that LRRC40 is found in nucleoli and slightly in the cytoplasm, with low protein stability despite normal mRNA levels, as confirmed by western blot analysis (Pijuan2021PLXNA2). These findings highlight the importance of LRRC40 in neuronal pathways and its potential involvement in neurodevelopmental disorders.


## References


[1. (Huang2022Identification) Guoping Huang and Jianhua Mao. Identification of a 12-gene signature and hub genes involved in kidney wilms tumor via integrated bioinformatics analysis. Frontiers in Oncology, April 2022. URL: http://dx.doi.org/10.3389/fonc.2022.877796, doi:10.3389/fonc.2022.877796. This article has 5 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fonc.2022.877796)

[2. (Pijuan2021PLXNA2) Jordi Pijuan, Juan Darío Ortigoza‐Escobar, Juan Ortiz, Adrián Alcalá, María José Calvo, Mariona Cubells, Cristina Hernando‐Davalillo, Francesc Palau, and Janet Hoenicka. <scp>plxna2</scp> and <scp>lrrc40</scp> as candidate genes in autism spectrum disorder. Autism Research, 14(6):1088–1100, March 2021. URL: http://dx.doi.org/10.1002/aur.2502, doi:10.1002/aur.2502. This article has 5 citations and is from a peer-reviewed journal.](https://doi.org/10.1002/aur.2502)

[3. (Cui2022Comprehensive) Zelong Cui, Yue Fu, Zongcheng Yang, Zhenxing Gao, Huimin Feng, Minran Zhou, Lu Zhang, and Chunyan Chen. Comprehensive analysis of a ferroptosis pattern and associated prognostic signature in acute myeloid leukemia. Frontiers in Pharmacology, May 2022. URL: http://dx.doi.org/10.3389/fphar.2022.866325, doi:10.3389/fphar.2022.866325. This article has 11 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fphar.2022.866325)